Indicaton

Milestone: IND enabling expected 2024

Our partner, Indivior, has licensed worldwide rights to our GABAB PAM program and is responsible for all development, manufacture and commercialization of any selected GABAB PAM drug candidates.

Therapeutic indications
Type of product
Table
  • Phase
    Discovery
  • Partnering status
    Partnered
  • Partner
    Indivior PLC